|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cyclophosphamide versus placebo in scleroderma lung disease显示文摘 | Tashkin DP Elashoff R Clements PJ | | 0，，25： | 1 |
| 2 | Sclerodermalung study (SLS): differences in the presentation andcourse of patients with limited versus diffuse systemicsclerosis显示文摘 | Clements PJ Roth MD Elashoff R | 2007 | Ann Rheum Dis2007，66，12： | 1 |
| 3 | Germination ofBacillus cereus spores in response to L-alanine and to inosine : theroles of gerL and gerQ operons显示文摘 | Barlass PJ Houston CW Clements MO | 2002 | Microbiology2002，148，7： | 1 |
| 4 | Skin thickness score as a predictor and correlate of outcome in systemic sclerosis:high-dose versus low-dose penicillamine trial显示文摘 | Clements PJ Hurwitz EL Wong WK | | 0，，： | 1 |
| 5 | Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease显示文摘 | Tashkin DP Elashoff R Clements PJ | 2007 | Am J Respir Crit Care Med2007，176，10： | 1 |
| 6 | Effects of I-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung dis画 ease显示文摘 | Tashkin DP Elashoff R Clements PJ | | Am J Respir Crlt Care0，176，10： | 1 |
| 7 | Predicto of mortality after total knee replacement 显示文摘 | Clement ND Jenkins PJ Brenkel IJ | 2012 | J Bone Joint Surg Br2012，94，： | 1 |
| 8 | The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH 显示文摘 | Clements PJ Tan M McLaughlin VV | 2012 | Ann Rheum Dis2012，71，： | 1 |
| 9 | Cyclophosphamide versus placebo in scleroderma lung disease显示文摘 | Tashkin DP Elashoff R Clements PJ | 2006 | N Engl J Med2006，354，25： | 1 |
| 10 | High- dose versus low dose Dpenicillamine in early diffuse systemic sclerosis:analysis of a two- year, double -blind,randomized,controlled clinical trial显示文摘 | Clements PJ Furst DE Wong WK | 1999 | Arthritis Rheum1999，42，： | 1 |
| 11 | Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease显示文摘 | Tashkin DP Elashoff R Clements PJ | 2007 | Am J Respir Crit Care Med2007，176，10： | 1 |
| 12 | Callous-unemotional traits, impulsivity, and emotional processing in antisocial adolescents显示文摘 | Loney BR Frick PJ Clements CB | 2003 | Clinical Child and Adolescent Psychology2003，32，1： | 1 |
| 13 | The co -distribution of Plasmodium falciparum and hookworm among African schoolchildren 显示文摘 | Brooker S Clements AC Hotez PJ | 2006 | Malaria J2006，3，5： | 1 |
| 14 | Infliximab may be effec- tive in the treatment of steroid-resistant eosinophilic fasci- itis:report of three cases 显示文摘 | Khanna D Agrawal H Clements PJ | 2010 | Rheumatology2010，49，6： | 1 |
| 15 | Responsiveness of the SF-36 and the Health Assessment Questionnaire Disa- bility Index in a systemic sclerosis clinical trial 显示文摘 | Khanna D Furst DE Clements PJ | 2005 | J Rheu- matol2005，32，5： | 1 |
| 16 | High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis:analysis of a two-year,double-blind,randomized,controlled clinical trial显示文摘 | Clements PJ Furst DE Wong WK | 1999 | Arthritis Rheum1999，42，6： | 1 |
| 17 | A comparison of the use of uneemented hydroxyapatite-coated bipolar and cemented femoral stems in the treatment of femoral neck fractures:a case-control study显示文摘 | Bell KR Clement ND Jenkins PJ | 2014 | Bone Joint J2014，96，3： | 1 |
| 18 | Cyclophosphamide versus placebo in scleroderma lung disease显示文摘 | Tashkin DP Elashoff R Clements PJ | 2006 | N Engl J Med2006，354，25： | 1 |
| 19 | Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement:a randomized,double-blind,placebo-controlled trial显示文摘 | Khanna D Clements PJ Furst DE | 2009 | Arthritis Rheum2009，60，4： | 1 |
| 20 | Cyclophosphamide versus placebo in scleroderma lung disease 显示文摘 | Tashkin DP Elashoff R Clements PJ | 2006 | N Engl J Med2006，354，25： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员